144 related articles for article (PubMed ID: 35805119)
41. Effects of autophagy inhibition by chloroquine on hepatic stellate cell activation in CCl4-induced acute liver injury mouse model.
Le TV; Dinh NBT; Dang MT; Phan NCL; Dang LTT; Grassi G; Holterman AXL; Le HM; Truong NH
J Gastroenterol Hepatol; 2022 Jan; 37(1):216-224. PubMed ID: 34713488
[TBL] [Abstract][Full Text] [Related]
42. Protective effects of total flavonoids of Bidens bipinnata L. against carbon tetrachloride-induced liver fibrosis in rats.
Yuan LP; Chen FH; Ling L; Bo H; Chen ZW; Li F; Zhong MM; Xia LJ
J Pharm Pharmacol; 2008 Oct; 60(10):1393-402. PubMed ID: 18812033
[TBL] [Abstract][Full Text] [Related]
43. Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice.
Lei XF; Fu W; Kim-Kaneyama JR; Omoto T; Miyazaki T; Li B; Miyazaki A
J Hepatol; 2016 Jan; 64(1):110-7. PubMed ID: 26334580
[TBL] [Abstract][Full Text] [Related]
44. Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo.
Tseng TH; Lin WL; Chen ZH; Lee YJ; Shie MS; Lee KF; Shen CH; Kuo HC
J Transl Med; 2016 Sep; 14(1):263. PubMed ID: 27612633
[TBL] [Abstract][Full Text] [Related]
45. Heparanase protects the heart against chemical or ischemia/reperfusion injury.
Wang F; Pulinilkunnil T; Flibotte S; Nislow C; Vlodavsky I; Hussein B; Rodrigues B
J Mol Cell Cardiol; 2019 Jun; 131():29-40. PubMed ID: 31004678
[TBL] [Abstract][Full Text] [Related]
46. Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice.
Wu Y; Li Z; Xiu AY; Meng DX; Wang SN; Zhang CQ
Drug Des Devel Ther; 2019; 13():2667-2676. PubMed ID: 31534314
[TBL] [Abstract][Full Text] [Related]
47. Heparanase expression upregulates platelet adhesion activity and thrombogenicity.
Cui H; Tan YX; Österholm C; Zhang X; Hedin U; Vlodavsky I; Li JP
Oncotarget; 2016 Jun; 7(26):39486-39496. PubMed ID: 27129145
[TBL] [Abstract][Full Text] [Related]
48. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis.
Son G; Iimuro Y; Seki E; Hirano T; Kaneda Y; Fujimoto J
Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G631-9. PubMed ID: 17640975
[TBL] [Abstract][Full Text] [Related]
49. Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
Chen W; Zhang Z; Yao Z; Wang L; Zhang F; Shao J; Chen A; Zheng S
Int Immunopharmacol; 2018 Mar; 56():148-155. PubMed ID: 29414645
[TBL] [Abstract][Full Text] [Related]
50. Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice.
Yu J; Wu CW; Chu ES; Hui AY; Cheng AS; Go MY; Ching AK; Chui YL; Chan HL; Sung JJ
Biochem Biophys Res Commun; 2008 Aug; 372(4):571-7. PubMed ID: 18503750
[TBL] [Abstract][Full Text] [Related]
51. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model.
Yoshiji H; Kuriyama S; Miyamoto Y; Thorgeirsson UP; Gomez DE; Kawata M; Yoshii J; Ikenaka Y; Noguchi R; Tsujinoue H; Nakatani T; Thorgeirsson SS; Fukui H
Hepatology; 2000 Dec; 32(6):1248-54. PubMed ID: 11093731
[TBL] [Abstract][Full Text] [Related]
52. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice.
Lamb CL; Cholico GN; Pu X; Hagler GD; Cornell KA; Mitchell KA
Toxicol Appl Pharmacol; 2016 Nov; 311():42-51. PubMed ID: 27693115
[TBL] [Abstract][Full Text] [Related]
53. Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation.
Zhong W; Gao L; Zhou Z; Lin H; Chen C; Huang P; Huang W; Zhou C; Huang S; Nie L; Liu Y; Chen Y; Zhou D; Lv Z
Oncotarget; 2017 Jun; 8(25):40486-40500. PubMed ID: 28465467
[TBL] [Abstract][Full Text] [Related]
54. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
55. Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice.
Hamzavi J; Ehnert S; Godoy P; Ciuclan L; Weng H; Mertens PR; Heuchel R; Dooley S
J Cell Mol Med; 2008 Oct; 12(5B):2130-44. PubMed ID: 18266971
[TBL] [Abstract][Full Text] [Related]
56. Deficiency of DJ-1 Ameliorates Liver Fibrosis through Inhibition of Hepatic ROS Production and Inflammation.
Yu Y; Sun X; Gu J; Yu C; Wen Y; Gao Y; Xia Q; Kong X
Int J Biol Sci; 2016; 12(10):1225-1235. PubMed ID: 27766037
[TBL] [Abstract][Full Text] [Related]
57. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
[TBL] [Abstract][Full Text] [Related]
58. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Yanase K; Namisaki T; Imazu H; Fukui H
Hepatology; 2002 Oct; 36(4 Pt 1):850-60. PubMed ID: 12297832
[TBL] [Abstract][Full Text] [Related]
59. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.
Sanz S; Pucilowska JB; Liu S; Rodríguez-Ortigosa CM; Lund PK; Brenner DA; Fuller CR; Simmons JG; Pardo A; Martínez-Chantar ML; Fagin JA; Prieto J
Gut; 2005 Jan; 54(1):134-41. PubMed ID: 15591519
[TBL] [Abstract][Full Text] [Related]
60. Crocin attenuates CCl
Chhimwal J; Sharma S; Kulurkar P; Patial V
Hum Exp Toxicol; 2020 Dec; 39(12):1639-1649. PubMed ID: 32633567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]